T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NOVA
1251
DELISTED
Sunnova Energy
NOVA
| $23M | ﹤0.01% |
822,135
+798,313
| +3,351% | +$28.8M |
|
1252
Pultegroup
PHM
$24.6B
| $22.9M | ﹤0.01% |
401,426
-33,567
| -8% | -$1.72M |
|
1253
Alliant Energy
LNT
$18.2B
| $22.9M | ﹤0.01% |
372,823
-18,580
| -5% | -$1.06M |
|
1254
John B. Sanfilippo & Son
JBSS
$989M
| $22.7M | ﹤0.01% |
251,634
-13,043
| -5% | -$1.12M |
|
1255
State Street SPDR Dow Jones REIT ETF
RWR
$1.89B
| $22.6M | ﹤0.01% |
185,341
| – | – |
|
1256
Pacira BioSciences
PCRX
$924M
| $22.6M | ﹤0.01% |
375,461
+3,873
| +1% | +$214K |
|
1257
DaVita
DVA
$11.6B
| $22.4M | ﹤0.01% |
196,675
-10,718
| -5% | -$1.15M |
|
1258
Cadre Holdings
CDRE
$1.44B
| $22.3M | ﹤0.01% |
+875,893
| New | +$17.8M |
|
1259
State Street Blackstone Senior Loan ETF
SRLN
$5.38B
| $22.2M | ﹤0.01% |
487,100
+130,000
| +36% | +$5.94M |
|
|
NXRT
1260
NexPoint Residential Trust
NXRT
$631M
| $22.1M | ﹤0.01% |
264,087
+35,803
| +16% | +$2.65M |
|
1261
J.M. Smucker
SJM
$12.7B
| $22.1M | ﹤0.01% |
162,421
-7,075
| -4% | -$902K |
|
1262
SolarEdge
SEDG
$1.98B
| $21.8M | ﹤0.01% |
77,766
+55,295
| +246% | +$17.5M |
|
1263
Whirlpool
WHR
$2.79B
| $21.8M | ﹤0.01% |
92,881
-4,764
| -5% | -$1.05M |
|
|
ARNC
1264
DELISTED
Arconic Corporation
ARNC
| $21.7M | ﹤0.01% |
656,277
-44,794
| -6% | -$1.39M |
|
1265
F5
FFIV
$24B
| $21.5M | ﹤0.01% |
87,803
-4,307
| -5% | -$956K |
|
1266
Maximus
MMS
$2.94B
| $21.4M | ﹤0.01% |
268,606
-118,137
| -31% | -$9.66M |
|
|
INN
1267
Summit Hotel Properties
INN
$656M
| $21.4M | ﹤0.01% |
2,191,070
+299,408
| +16% | +$2.91M |
|
1268
The Mosaic Company
MOS
$6.92B
| $21.3M | ﹤0.01% |
543,304
+11,988
| +2% | +$459K |
|
1269
Robert Half
RHI
$4.25B
| $21.3M | ﹤0.01% |
191,295
-8,277
| -4% | -$922K |
|
1270
FMC
FMC
$1.28B
| $21.3M | ﹤0.01% |
194,094
-7,217
| -4% | -$726K |
|
1271
Blackstone Mortgage Trust
BXMT
$2.41B
| $21.2M | ﹤0.01% |
692,493
-1,746
| -0.3% | -$55.5K |
|
1272
Ponce Financial Group
PDLB
$500M
| $21.1M | ﹤0.01% |
2,013,005
| – | – |
|
|
ACCD
1273
DELISTED
Accolade Inc
ACCD
| $21.1M | ﹤0.01% |
799,700
-528,423
| -40% | -$17.3M |
|
1274
Ameris Bancorp
ABCB
$5.94B
| $20.9M | ﹤0.01% |
421,319
-1,190
| -0.3% | -$61.5K |
|
|
KRON
1275
DELISTED
Kronos Bio
KRON
| $20.8M | ﹤0.01% |
1,533,562
-239,621
| -14% | -$3.75M |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.